{
    "code": "56028437",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56028437",
    "time": "2020-02-26 07:55:29",
    "許可證字號": "衛部醫器輸字第028437號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/06\/03",
    "發證日期": "105\/06\/03",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602843705",
    "中文品名": "宜立亞甲狀腺球蛋白抗體檢測試劑",
    "英文品名": "EliA anti-TG Well",
    "效能": "宜立亞甲狀腺球蛋白抗體檢測試劑用於體外定量，測定人體血清和血漿中甲狀腺球蛋白(thyroglobulin, TG)之IgG抗體，進而協助臨床診斷甲狀腺疾病，像是自體免疫甲狀腺炎(autoimmunethyroiditis)和葛瑞夫茲氏症(Graves' disease)。宜立亞甲狀腺球蛋白抗體檢測試劑使用宜立亞IgG方法於法迪亞250儀器進行檢測。",
    "醫器規格": "14‐5642‐41。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "620110P095  台灣法迪亞股份有限公司",
        "申請商地址": "台北市內湖區洲子街85號6樓之1",
        "主製造廠": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560284370001-105-06-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56028437&Seq=001&Type=9"
        },
        {
            "title": "560284370002-105-06-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56028437&Seq=001&Type=8"
        }
    ]
}